Vimarsana
Biggest News Aggregation in the World

Protocol Assistance News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Protocol Assistance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Protocol Assistance Today - Breaking & Trending Today

Sage Therapeutics, Inc.: Sage Therapeutics Announces European Medicines Agency Granted SAGE-718 Orphan Drug Designation for the Treatment of Huntington's Disease - Vimarsana News

Sage Therapeutics, Inc.: Sage Therapeutics Announces European Medicines Agency Granted SAGE-718 Orphan Drug Designation for the Treatment of Huntington's Disease

Published: February 22, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, today announced the European Medicines Agency (EMA) granted Orphan Drug

Source: finanznachrichten.de
Related Topics:
Dennis RiedlHelen RubinsteinMatthew HensonLaura GaultExchange CommissionSage Therapeutics IncEuropean Medicines AgencySage TherapeuticsOrphan Drug DesignationChief Medical OfficerProtocol AssistanceFast Track DesignationPrivate Securities Litigation Reform Act
MaaT Pharma Provides Corporate Update and Highlights Key Expected Milestones in 2023 - Vimarsana News

MaaT Pharma Provides Corporate Update and Highlights Key Expected Milestones in 2023

Published: January 24, 2023

Regulatory News: MaaT Pharma (EURONEXT: MAAT the "Company"), a French clinical-stage biotech and a pioneer in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to improving

Source: finanznachrichten.de
Related Topics:
United StatesFrance GeneralWaals GewestTrophic Communications CorporateDrug AdministrationUs CentersEuropean Medical AgencyInnovation Task ForceAmerican Society Of HematologySenior Pr Corporate CommunicationsInternational Human Microbiome ConsortiumRegulatory NewsMicrobiome EcosystemMaat PharmaMicrobiome Ecosystem TherapyGraft Versus Host DiseaseOrphan Drug DesignationInvestigational New DrugBiologics EvaluationProtocol AssistanceImmune Checkpoint InhibitorsTask ForceMicrobiome Ecosystem TherapiesEuronext ParisCommunications Manager